DATATRAK Deploys Oracle(R) Real Application Clusters In Its Global Data Center Implementation of Oracle Real Application Clusters is Unique in the EDC Market and Further Enhances DATATRAK's Scalability and Performance as a Global ASP CLEVELAND, April 12 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (Nasdaq: "DATA"), the leading and most experienced Application Service Provider ("ASP") in the Electronic Data Capture ("EDC") industry, today announced they have placed into production in their global data center in Cleveland the first international EDC clinical trial utilizing Oracle(R) Real Application Clusters. Oracle Real Application Clusters is a sophisticated architecture that allows for the automatic parallel shifting of availability demands across multiple database servers simultaneously. This new architecture supercedes the functionality of previous environments using distributed database servers and matches the exceptional performance and availability of Terminal server clusters. This unique implementation offers advantages for users because it guarantees continued rapid response times, even though the sizes of the company's databases continue to increase as the EDC market expands. This new architecture is timely with the expected increase in Technology Transfers in 2004 and 2005 which will result in more users creating their own studies and accessing their own reports with the DATATRAK EDC(R) Product Suite. A growing number of worldwide users can cause hundreds of requests for information access to hit a database simultaneously. Moreover, such requests can be for complex reports that need to search thousands of patient records quickly. With Oracle Real Application Clusters, DATATRAK can extend its excellent reputation for outstanding service and system performance. This technical advancement also has implications for internal operations and their associated costs. Oracle Real Application Clusters allows DATATRAK to further leverage current investments in infrastructure because the load- balancing automatically modulates database requirements with instantaneous demand, reducing the need for more hardware and personnel in order to manage greater amounts of business. "Oracle Real Application Clusters provides me with a tremendously improved opportunity to better serve our customers through significant advancements in serviceability, scalability and availability", stated Jeffrey Cowen, DATATRAK's Database Administrator. "We are the most experienced and the leading ASP in the EDC market and this advancement supports that claim", stated Dr. Jeffrey A. Green, President and Chief Executive Officer of DATATRAK International, Inc. "The first phrase is clear as we have been implementing EDC since1993 -- longer than any other company in this market. The second phrase is supported by the innovative efforts represented by this announcement. Implementation of this sophisticated platform by our technical team is unique to this industry and establishes the foundation to handle large volumes of business with a high degree of service and availability for our customers." Green continued, "There are less expensive ways to 'play' this market other than making the investment of time and money into such advancements, but the short-cuts eventually catch up with you and then shareholders and customers are usually left holding the bag. We have never taken that approach, because we believe this industry should consider its data too important to be trusted to the lowest bidder. Quality doesn't cost -- it pays. We take our own advice because we have chosen to invest extensively in systems over the past four years instead of headcount in order to best manage our growth. As an indication of this leverage, we have experienced over a 3,500% revenue growth since 1998 and we have only added in that time two people in our technical services department." About DATATRAK International DATATRAK International, Inc. is a worldwide ASP for the EDC industry. The Company provides a suite of software products supporting the use of DATATRAK EDCO and related services to the pharmaceutical, biotechnology, and medical device industries. DATATRAK EDCO was developed in order to deliver clinical research data from investigative sites to clinical trial sponsors faster and more efficiently than conventional, manual methods. DATATRAK EDCO can be deployed worldwide in either a distributed platform using laptop computers or in a centralized environment using the Internet. DATATRAK EDCO software and its earlier versions have successfully supported many international clinical studies involving thousands of clinical research sites and encompassing tens of thousands of patients in over 40 countries. DATATRAK International, Inc.'s product suite has been utilized in some aspect of the clinical development of 14 separate drugs that have received regulatory approval from either the United States Food and Drug Administration or counterpart European bodies. DATATRAK International, Inc. has offices located in Cleveland, Ohio and Bonn, Germany. Its common stock is listed on the Nasdaq Stock Market under the symbol "DATA." Visit the DATATRAK International, Inc. web site at http://www.datatraknet.com/ or http://www.datatraknet.de/. Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. Factors that may cause actual results to differ materially from those in the forward- looking statements include the ability of the Company to absorb corporate overhead and other fixed costs in order to successfully market the DATATRAK EDCO software; the development and fluctuations in the market for EDC technology; continued unreliability of the Internet infrastructure; the degree of the Company's success in obtaining new contracts; the timing of payments from customers and the timing of clinical trial sponsor decisions to conduct new clinical trials or cancel or delay ongoing trials; dependence onkey personnel; governmental regulation; the early stage of the Company's EDC business and operations; and general economic conditions. In addition, the Company's success depends on the outcome of various strategic initiatives it has undertaken, all ofwhich are based on assumptions made by the Company concerning trends in the clinical research market and the health care industry. DATASOURCE: DATATRAK International, Inc. CONTACT: Jeffrey A. Green, Pharm.D., FCP, President and Chief Executive Officer, +1-440-443-0082, ext. 112, or Terry C. Black, Chief Financial Officer, +1-440-443-0082, ext. 110, both of DATATRAK International, Inc. Web site: http://www.datatraknet.com/ http://www.datatraknet.de/

Copyright